Ubiquinol and Precision Mitochondrial Nutrition for Fertility
A growing body of science is reshaping how clinicians and formulators think about fertility – not just as a hormonal or structural issue, but as a mitochondrial one. A new peer-reviewed review, “Ubiquinol in Fertility and Reproduction: A Conditionally Essential Nutrient for Critical Early-Life Stages”, published in Nutrients (January 2026) places Kaneka Ubiquinol™ at the centre of this conversation, highlighting its emerging role as a conditionally essential nutrient for reproductive health.
Against a backdrop where the World Health Organization (WHO) estimates that infertility affects nearly one in six people globally, the review synthesises evidence linking oxidative stress, mitochondrial dysfunction and declining reproductive outcomes in both men and women.
Why mitochondria matter for fertility
Gametes and early embryos are among the most energy-demanding and oxidative stress-sensitive cells in the human body. To mature, fertilise and develop properly, they rely on robust mitochondrial ATP/energy production and tight control of reactive oxygen species (ROS). The Nutrients review – authored by Dr Emma J Derbyshire, Professor Sergej M Ostojic and Dr Ahmed T Alhamar – brings these strands of research together and positions Ubiquinol, the reduced and bioactive form of coenzyme Q10 (CoQ10), as a key player in this process.
Ubiquinol fulfils a dual role in reproductive physiology:
- It is a central cofactor in the mitochondrial electron transport chain, supporting ATP generation.
- It acts as a potent lipid-soluble antioxidant, helping to protect delicate cellular structures – including sperm membranes and oocyte mitochondria – from oxidative damage.
These functions are particularly relevant as couples attempt to conceive later in life. Endogenous production of Ubiquinol declines with age, just as oxidative stress increases due to lifestyle factors (such as smoking, high alcohol intake and obesity) and environmental toxin exposure.
From non-essential to “conditionally essential”
Under normal circumstances, the body can synthesise sufficient Ubiquinol to meet baseline needs. However, the review suggests that during high-demand states – including the reproductive years, advanced maternal and paternal age, and pregnancy – internal production may no longer keep pace with cellular requirements.
Dietary patterns may further widen this gap. Ubiquinol is found predominantly in animal-derived foods such as organ meats, certain fish, eggs and dairy; intake may be lower in individuals following plant-based or low-meat diets.
Taken together, these factors create a scenario in which Ubiquinol behaves less like a “nice-to-have” and more like a conditionally essential nutrient – one that becomes critical when physiological demand, age or diet reduce the margin of safety for mitochondrial function and antioxidant defence.
Emerging evidence in male and female fertility
The Nutrients review collates a series of clinical and preclinical studies exploring Ubiquinol in fertility settings. In men with idiopathic infertility, trials using 200-400 mg/day Ubiquinol for 3-5 months have consistently reported improvements in sperm concentration, motility, morphology and markers of oxidative stress, alongside reductions in sperm DNA fragmentation.
While live birth and pregnancy outcomes are influenced by many factors and remain less thoroughly studied, these data point to Ubiquinol as a promising tool for supporting sperm quality and mitochondrial resilience in the male partner.
In women, the picture is more preliminary but equally intriguing. Emerging data confirmed via preclinical and clinical human studies suggest that Ubiquinol can support oocyte mitochondrial function, help maintain oocyte quality with age and, in some settings, improve ovarian responsiveness to ovulation induction or IVF protocols, particularly in women with polycystic ovary syndrome (PCOS) or diminished ovarian reserve.
The review also highlights work in pregnancy and early life, where Ubiquinol status appears to rise as gestation progresses, and supplementation in high-risk women has been associated with a reduced risk of pre-eclampsia – an area where future research may further clarify Ubiquinol’s role.
Precision mitochondrial nutrition for reproductive health
Crucially, the authors emphasise that not all CoQ10 is the same. Ubiquinol is the biologically active, reduced form, distinguished by superior bioavailability in head-to-head comparisons with oxidised CoQ10. In clinical studies, Ubiquinol reaches higher circulating levels at equivalent doses, offering a potential advantage when the goal is to rapidly and reliably support mitochondrial function in time-sensitive fertility protocols.
For Kaneka, this aligns directly with the concept of precision mitochondrial nutrition – tailoring nutrient inputs to the specific bioenergetic and oxidative stress demands of reproductive tissues, rather than relying on broad, non-specific antioxidant strategies.
The review argues that fertility support is poised to move beyond generic antioxidant blends towards more targeted interventions that address mitochondrial performance in sperm, oocytes and early embryos.
While the Nutrients review calls for continued clinical investigation, it clearly positions Ubiquinol as a foundational nutrient in reproductive bioenergetics and oxidative balance – and as a differentiated ingredient for forward-thinking fertility formulations aimed at both men and women.
For healthcare practitioners and brand partners alike, these findings reinforce the value of integrating Kaneka Ubiquinol™ into evidence-informed strategies to support fertility in an ageing, high-stress world.
Reference: Derbyshire EJ, Ostojic SM, Alhamar AT. Ubiquinol in Fertility and Reproduction: A Conditionally Essential Nutrient for Critical Early-Life Stages. Nutrients 2026;18(1):156.
Always read the label and follow the directions for use. Consult your healthcare professional to establish if Ubiquinol is suitable for your needs.